| 000 | 01754 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514182001.0 | ||
| 264 | 0 | _c20040420 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1111/j.1365-2249.2003.02391.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJones, B M | |
| 245 | 0 | 0 |
_aProlonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMar 2004 |
||
| 300 |
_a467-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 |
_aLeukocytes _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aLymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhytohemagglutinins _ximmunology |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 |
_aSevere Acute Respiratory Syndrome _xdrug therapy |
| 700 | 1 | _aMa, E S K | |
| 700 | 1 | _aPeiris, J S M | |
| 700 | 1 | _aWong, P C | |
| 700 | 1 | _aHo, J C M | |
| 700 | 1 | _aLam, B | |
| 700 | 1 | _aLai, K N | |
| 700 | 1 | _aTsang, K W T | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 135 _gno. 3 _gp. 467-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2003.02391.x _zAvailable from publisher's website |
| 999 |
_c14728926 _d14728926 |
||